Work

PP01.19: A Phase 1b Clinical Study of NXP900 in Combination with Osimertinib in Patients with Advanced, EGFRMut+ Non-Small Cell Lung Cancer (Study NXP900-103) (Trial in Progress)

Year: 2026

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2026.104017

Authors: Kai-li Liang, Alexander Spira, Jennifer Segar, Christina Baik, Lyudmila Bazhenova, Mohit Narang, Mark Sloan, Allison Woods, Zofia Piotrowska

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7167235646

Cites:

Cited by:

Related to: